Company: PFSA
Filing Date: 2025-08-14
Form Type: 10-Q
Source: 0001213900-25-076861
Chunk: 95

Company: Profusa, Inc.
Filing Date: 2025-08-14
Form: 10-Q
Item: Part I, Item 8
Chunk 95
---
under (together with the other transactions contemplated by the Merger Agreement, the “Business
Combination”).

On July 11, 2025 (the “Closing Date”),
the Company closed the Business Combination with Profusa. As a result of the Business Combination, the Company owns 100% of the outstanding
common stock of Profusa.

In connection with the closing of the Business
Combination, the Company changed its name from “NorthView Acquisition Corporation” to “Profusa, Inc.”

Business Prior to the Business Combination

On December 22, 2021, the Company consummated
its Initial Public Offering (“IPO”) of 18,975,000 units (the “Units”), which included 2,475,000 Units issued
pursuant to the full exercise of the over-allotment option granted to the underwriters. Each Unit consists of one share of common stock
of the Company, par value $0.0001 per share, one right (the “Rights”), and one-half of one redeemable warrant of the Company
(the “Warrants”). Each Right entitles the holder thereof to receive one-tenth (1/10) of one share of common stock. Each Warrant
entitles the holder thereof to purchase one share of common stock for $11.50 per share, subject to adjustment. The Units were sold at
a price of $10.00 per Unit, generating gross proceeds to the Company of $189,750,000.

Simultaneously with the closing of the IPO, the
Company completed the private sale of an aggregate of 7,347,500 warrants (the “Private Placement Warrants”), which included
697,500 Private Placement Warrants issued pursuant to the full exercise of the over-allotment option granted to the underwriters, to
NorthView Sponsor I, LLC (“the Sponsor”), I-Bankers Securities, Inc., and Dawson James Securities, Inc. at a purchase price
of $1.00 per Private Placement Warrant, generating gross proceeds to the Company of $7,347,500, which is discussed in Note 4.

Transaction costs in connection with the IPO
amounted to $7,959,726, consisting of $3,450,000 of underwriting discount, $3,570,576 of Representative’s Shares cost, $259,527
of Representative’s Warrants cost and $679,623 of other offering costs.

Following the closing of the IPO on December
22,